PMDA关于批准和修订抗癌药物使用注意事项的监管更新；日本批准了用于乳腺癌的sacituzumab govitecan、用于结直肠癌的fruquintinib、用于肺癌的amivantamab、用于肺癌的repotrectinib、用于胆道癌的tasurgratinib、用于尿道癌的enfortumab vedotin plus pembrolizumab以及用于胶质瘤的dabrafenib plus trametinib。

{"title":"PMDA关于批准和修订抗癌药物使用注意事项的监管更新；日本批准了用于乳腺癌的sacituzumab govitecan、用于结直肠癌的fruquintinib、用于肺癌的amivantamab、用于肺癌的repotrectinib、用于胆道癌的tasurgratinib、用于尿道癌的enfortumab vedotin plus pembrolizumab以及用于胶质瘤的dabrafenib plus trametinib。","authors":"Noriomi Matsumura, Masaki Mandai","doi":"10.1007/s10147-024-02644-7","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":13869,"journal":{"name":"International Journal of Clinical Oncology","volume":" ","pages":"1775-1776"},"PeriodicalIF":2.4000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs; approval of sacituzumab govitecan for breast cancer, fruquintinib for colorectal cancer, amivantamab for lung cancer, repotrectinib for lung cancer, tasurgratinib for biliary tract cancer, enfortumab vedotin plus pembrolizumab for urothelial cancer, and dabrafenib plus trametinib for glioma in Japan.\",\"authors\":\"Noriomi Matsumura, Masaki Mandai\",\"doi\":\"10.1007/s10147-024-02644-7\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":13869,\"journal\":{\"name\":\"International Journal of Clinical Oncology\",\"volume\":\" \",\"pages\":\"1775-1776\"},\"PeriodicalIF\":2.4000,\"publicationDate\":\"2024-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Clinical Oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s10147-024-02644-7\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Clinical Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10147-024-02644-7","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}